We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Eupraxia Pharmaceuticals Inc | TSX:EPRX.WT.A | Toronto | Equity Warrant |
Price Change | % Change | Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
0.00 | 0.00% | 1.20 | 1.50 | 3.00 |
High Price | Low Price | Open Price | Traded | Last Trade |
---|---|---|---|---|
0 | 00:00:00 |
Date | Price | Price Change | Price % Change | Low Price | High Price | Traded |
---|---|---|---|---|---|---|
29 Nov 2024 | 1.20 | 0.00 | 0.00% | 1.20 | 1.20 | 0 |
28 Nov 2024 | 1.20 | 0.00 | 0.00% | 1.20 | 1.20 | 0 |
27 Nov 2024 | 1.20 | 0.00 | 0.00% | 1.20 | 1.20 | 0 |
26 Nov 2024 | 1.20 | 0.00 | 0.00% | 1.20 | 1.20 | 0 |
25 Nov 2024 | 1.20 | 0.00 | 0.00% | 1.20 | 1.20 | 0 |
22 Nov 2024 | 1.20 | 0.00 | 0.00% | 1.20 | 1.20 | 0 |
21 Nov 2024 | 1.20 | 0.00 | 0.00% | 1.20 | 1.20 | 0 |
20 Nov 2024 | 1.20 | 0.00 | 0.00% | 1.20 | 1.20 | 0 |
19 Nov 2024 | 1.20 | 0.00 | 0.00% | 1.20 | 1.20 | 0 |
18 Nov 2024 | 1.20 | 0.00 | 0.00% | 1.20 | 1.20 | 0 |
15 Nov 2024 | 1.20 | 0.00 | 0.00% | 1.20 | 1.20 | 0 |
14 Nov 2024 | 1.20 | 0.00 | 0.00% | 1.20 | 1.20 | 0 |
13 Nov 2024 | 1.20 | 0.00 | 0.00% | 1.20 | 1.20 | 0 |
12 Nov 2024 | 1.20 | -0.05 | -4.00% | 1.20 | 1.20 | 100 |
11 Nov 2024 | 1.25 | -0.20 | -13.79% | 1.25 | 1.25 | 100 |
08 Nov 2024 | 1.45 | 0.23 | 18.85% | 1.45 | 1.45 | 600 |
07 Nov 2024 | 1.22 | -0.24 | -16.44% | 1.22 | 1.22 | 500 |
06 Nov 2024 | 1.46 | 0.00 | 0.00% | 1.46 | 1.46 | 0 |
05 Nov 2024 | 1.46 | 0.00 | 0.00% | 1.46 | 1.46 | 0 |
04 Nov 2024 | 1.46 | 0.00 | 0.00% | 1.46 | 1.46 | 0 |
01 Nov 2024 | 1.46 | 0.00 | 0.00% | 1.46 | 1.46 | 0 |
31 Oct 2024 | 1.46 | 0.00 | 0.00% | 1.46 | 1.46 | 0 |
30 Oct 2024 | 1.46 | 0.00 | 0.00% | 1.46 | 1.46 | 0 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions